Pharmaceuticals - Community Register


List of Orphan refusals for human medicinal products


Product name: Tariquidar
Active substance: Tariquidar
Indication: Treatment of P-gp positive breast cancer
Marketing Authorisation Holder: Avaant Holdings Ltd

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/07/2012 Refusal of orphan designation EMA/OD/146/11 (2012)5533 of 27/07/2012